pubmed-article:20920772 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:20920772 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:20920772 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
pubmed-article:20920772 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:20920772 | lifeskim:mentions | umls-concept:C0002994 | lld:lifeskim |
pubmed-article:20920772 | lifeskim:mentions | umls-concept:C0019243 | lld:lifeskim |
pubmed-article:20920772 | lifeskim:mentions | umls-concept:C1304680 | lld:lifeskim |
pubmed-article:20920772 | lifeskim:mentions | umls-concept:C0205178 | lld:lifeskim |
pubmed-article:20920772 | lifeskim:mentions | umls-concept:C1261512 | lld:lifeskim |
pubmed-article:20920772 | lifeskim:mentions | umls-concept:C0699795 | lld:lifeskim |
pubmed-article:20920772 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:20920772 | pubmed:dateCreated | 2010-10-5 | lld:pubmed |
pubmed-article:20920772 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20920772 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20920772 | pubmed:abstractText | Hereditary angioedema (HAE) results from a genetic deficiency of C1-inhibitor. Two similar independent, randomized, saline controlled, double-blind studies were conducted to evaluate the efficacy and safety of recombinant human C1-inhibitor (rhC1INH) as a treatment of acute angioedema attacks in patients with HAE. | lld:pubmed |
pubmed-article:20920772 | pubmed:language | eng | lld:pubmed |
pubmed-article:20920772 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20920772 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:20920772 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20920772 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20920772 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:20920772 | pubmed:month | Oct | lld:pubmed |
pubmed-article:20920772 | pubmed:issn | 1097-6825 | lld:pubmed |
pubmed-article:20920772 | pubmed:author | pubmed-author:HackC ErikCE | lld:pubmed |
pubmed-article:20920772 | pubmed:author | pubmed-author:KaufmanLeonar... | lld:pubmed |
pubmed-article:20920772 | pubmed:author | pubmed-author:CicardiMarcoM | lld:pubmed |
pubmed-article:20920772 | pubmed:author | pubmed-author:NuijensJan... | lld:pubmed |
pubmed-article:20920772 | pubmed:author | pubmed-author:HaaseGeraldG | lld:pubmed |
pubmed-article:20920772 | pubmed:author | pubmed-author:ZurawBruceB | lld:pubmed |
pubmed-article:20920772 | pubmed:author | pubmed-author:LevyRobyn JRJ | lld:pubmed |
pubmed-article:20920772 | pubmed:author | pubmed-author:RelanAnuragA | lld:pubmed |
pubmed-article:20920772 | pubmed:author | pubmed-author:VisscherSonja... | lld:pubmed |
pubmed-article:20920772 | pubmed:copyrightInfo | Copyright © 2010 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved. | lld:pubmed |
pubmed-article:20920772 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:20920772 | pubmed:volume | 126 | lld:pubmed |
pubmed-article:20920772 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:20920772 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:20920772 | pubmed:pagination | 821-827.e14 | lld:pubmed |
pubmed-article:20920772 | pubmed:meshHeading | pubmed-meshheading:20920772... | lld:pubmed |
pubmed-article:20920772 | pubmed:meshHeading | pubmed-meshheading:20920772... | lld:pubmed |
pubmed-article:20920772 | pubmed:meshHeading | pubmed-meshheading:20920772... | lld:pubmed |
pubmed-article:20920772 | pubmed:meshHeading | pubmed-meshheading:20920772... | lld:pubmed |
pubmed-article:20920772 | pubmed:meshHeading | pubmed-meshheading:20920772... | lld:pubmed |
pubmed-article:20920772 | pubmed:meshHeading | pubmed-meshheading:20920772... | lld:pubmed |
pubmed-article:20920772 | pubmed:meshHeading | pubmed-meshheading:20920772... | lld:pubmed |
pubmed-article:20920772 | pubmed:meshHeading | pubmed-meshheading:20920772... | lld:pubmed |
pubmed-article:20920772 | pubmed:meshHeading | pubmed-meshheading:20920772... | lld:pubmed |
pubmed-article:20920772 | pubmed:meshHeading | pubmed-meshheading:20920772... | lld:pubmed |
pubmed-article:20920772 | pubmed:meshHeading | pubmed-meshheading:20920772... | lld:pubmed |
pubmed-article:20920772 | pubmed:meshHeading | pubmed-meshheading:20920772... | lld:pubmed |
pubmed-article:20920772 | pubmed:meshHeading | pubmed-meshheading:20920772... | lld:pubmed |
pubmed-article:20920772 | pubmed:year | 2010 | lld:pubmed |
pubmed-article:20920772 | pubmed:articleTitle | Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema. | lld:pubmed |
pubmed-article:20920772 | pubmed:affiliation | Department of Medicine, University of California San Diego and San Diego VA Healthcare, La Jolla, CA, USA. | lld:pubmed |
pubmed-article:20920772 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:20920772 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
pubmed-article:20920772 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:20920772 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:20920772 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:20920772 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:20920772 | lld:pubmed |